Skip to content
PubMed This is a summary of 85 peer-reviewed journal articles Updated

Research & Literature

Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.

Explore the Literature Visualize citation networks across 85 referenced papers

Top Authors

Puay Hoon Tan
National University of Singapore
Karla Kerlikowske
San Francisco VA Medical Center
Diana L. Miglioretti
Kaiser Permanente Washington Health Research Institute
Brian L. Sprague
University of Vermont
Celine M. Vachon
Mayo Clinic in Florida
Emad A. Rakha
Nottingham University Hospitals NHS Trust
Ian O. Ellis
Nottingham University Hospitals NHS Trust
Priscilla J. Slanetz
Boston University
Jeffrey A. Tice
University of California, San Francisco
Charlotte C. Gard
New Mexico State University

Top Institutions

Ranked by publications Top 10 institutions
03

Kaiser Permanente Washington Health Research Institute

Seattle, United States

24 papers
04

San Francisco VA Medical Center

San Francisco, United States

24 papers
Contributors Karla Kerlikowske
06

Nottingham University Hospitals NHS Trust

Nottingham, United Kingdom

10 papers
08

University of Vermont

Burlington, United States

17 papers

References

References (85)
  1. 1

    Nonpalpable BI-RADS 4 breast lesions: sonographic findings and pathology correlation.

    Elverici E, Barça AN, Aktaş H, et al.

    Diagnostic and interventional radiology (Ankara, Turkey) 2015; (21(3)):189-94 doi:10.5152/dir.2014.14103.

    PMID: 25835079
  2. 2

    Complex fibroadenoma and breast cancer risk: a Mayo Clinic Benign Breast Disease Cohort Study.

    Nassar A, Visscher DW, Degnim AC, et al.

    Breast cancer research and treatment 2015; (153(2)):397-405 doi:10.1007/s10549-015-3535-8.

    PMID: 26264469
  3. 3

    Breast Density and Benign Breast Disease: Risk Assessment to Identify Women at High Risk of Breast Cancer.

    Tice JA, Miglioretti DL, Li CS, et al.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2015; (33(28)):3137-43 doi:10.1200/JCO.2015.60.8869.

    PMID: 26282663
  4. 4

    Improving Patient Care by Incorporation of Multidisciplinary Breast Radiology-Pathology Correlation Conference.

    Prakash S, Venkataraman S, Slanetz PJ, et al.

    Canadian Association of Radiologists journal = Journal l'Association canadienne des radiologistes 2016; (67(2)):122-9.

    PMID: 26632099
  5. 5

    Practice Bulletin No. 164: Diagnosis and Management of Benign Breast Disorders.

    Obstetrics and gynecology 2016; (127(6)):e141-e156 doi:10.1097/AOG.0000000000001482.

    PMID: 27214189
  6. 6

    ACR Appropriateness Criteria Palpable Breast Masses.

    Harvey JA, Mahoney MC, Newell MS, et al.

    Journal of the American College of Radiology : JACR 2016; (13(11S)):e31-e42 doi:10.1016/j.jacr.2016.09.022.

    PMID: 27814822
  7. 7

    Can a pathological complete response of breast cancer after neoadjuvant chemotherapy be diagnosed by minimal invasive biopsy?

    Heil J, Schaefgen B, Sinn P, et al.

    European journal of cancer (Oxford, England : 1990) 2016; (69()):142-150 doi:10.1016/j.ejca.2016.09.034.

    PMID: 27821317
  8. 8

    Family History of Breast Cancer, Breast Density, and Breast Cancer Risk in a U.S. Breast Cancer Screening Population.

    Ahern TP, Sprague BL, Bissell MCS, et al.

    Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2017; (26(6)):938-944 doi:10.1158/1055-9965.EPI-16-0801.

    PMID: 28096200
  9. 9

    First ultrasound diagnosis of BI-RADS 3 lesions in young patients: Can 6-months follow-up be sufficient to assess stability?

    Marcon M, Frauenfelder T, Becker AS, et al.

    European journal of radiology 2017; (89()):226-233 doi:10.1016/j.ejrad.2017.02.012.

    PMID: 28267544
  10. 10

    Minimally Invasive Breast Fibroadenoma Excision Using an Ultrasound-Guided Vacuum-Assisted Biopsy Device.

    Papathemelis T, Heim S, Lux MP, et al.

    Geburtshilfe und Frauenheilkunde 2017; (77(2)):176-181 doi:10.1055/s-0043-100387.

    PMID: 28331240
  11. 11

    ACR Appropriateness Criteria® Palpable Breast Masses.

    , Moy L, Heller SL, et al.

    Journal of the American College of Radiology : JACR 2017; (14(5S)):S203-S224 doi:10.1016/j.jacr.2017.02.033.

    PMID: 28473077
  12. 12

    Fibroepithelial lesions; The WHO spectrum.

    Krings G, Bean GR, Chen YY

    Seminars in diagnostic pathology 2017; (34(5)):438-452 doi:10.1053/j.semdp.2017.05.006.

    PMID: 28688536
  13. 13

    [Five-year experience with the multidisciplinary evaluation of breast lesions according to the Decker radio-pathologic correlation system].

    Cserni G, Ambrózay É, Serfőző O

    Orvosi hetilap 2017; (158(28)):1100-1108 doi:10.1556/650.2017.30790.

    PMID: 28691880
  14. 14

    Utility of BI-RADS Assessment Category 4 Subdivisions for Screening Breast MRI.

    Strigel RM, Burnside ES, Elezaby M, et al.

    AJR. American journal of roentgenology 2017; (208(6)):1392-1399 doi:10.2214/AJR.16.16730.

    PMID: 28792802
  15. 15

    Combining quantitative and qualitative breast density measures to assess breast cancer risk.

    Kerlikowske K, Ma L, Scott CG, et al.

    Breast cancer research : BCR 2017; (19(1)):97 doi:10.1186/s13058-017-0887-5.

    PMID: 28830497
  16. 16

    Evaluating imaging-pathology concordance and discordance after ultrasound-guided breast biopsy.

    Park VY, Kim EK, Moon HJ, et al.

    Ultrasonography (Seoul, Korea) 2018; (37(2)):107-120 doi:10.14366/usg.17049.

    PMID: 29169231
  17. 17

    Genetics and genomics of breast fibroadenomas.

    Loke BN, Md Nasir ND, Thike AA, et al.

    Journal of clinical pathology 2018; (71(5)):381-387 doi:10.1136/jclinpath-2017-204838.

    PMID: 29248888
  18. 18

    BI-RADS 3: Current and Future Use of Probably Benign.

    Lee KA, Talati N, Oudsema R, et al.

    Current radiology reports 2018; (6(2)):5 doi:10.1007/s40134-018-0266-8.

    PMID: 29399419
  19. 19

    Specialized Second Opinion Interpretations of Breast Imaging: Impact on Additional Workup and Management.

    Weinfurtner RJ, Niell B, Mekhail Y, et al.

    Clinical breast cancer 2018; (18(5)):e1031-e1036 doi:10.1016/j.clbc.2018.03.009.

    PMID: 29625911
  20. 20

    Recurrent juvenile fibroadenoma of the breast in an adolescent: A case report.

    Huang IC, Li PC, Ding DC

    Medicine 2018; (97(20)):e10765 doi:10.1097/MD.0000000000010765.

    PMID: 29768365
  21. 21

    Is excision biopsy of fibroadenomas based solely on size criteria warranted?

    Neville G, Neill CO, Murphy R, et al.

    The breast journal 2018; (24(6)):981-985 doi:10.1111/tbj.13069.

    PMID: 29802656
  22. 22

    Subtypes of Benign Breast Disease as a Risk Factor of Breast Cancer: A Systematic Review and Meta Analyses.

    Salamat F, Niakan B, Keshtkar A, et al.

    Iranian journal of medical sciences 2018; (43(4)):355-364.

    PMID: 30046203
  23. 23

    Breast fibroadenomas are not associated with increased breast cancer risk in an African American contemporary cohort of women with benign breast disease.

    Shaik AN, Ruterbusch JJ, Abdulfatah E, et al.

    Breast cancer research : BCR 2018; (20(1)):91 doi:10.1186/s13058-018-1027-6.

    PMID: 30092846
  24. 24

    Intermediate and long-term outcomes of fibroadenoma excision in adolescent and young adult patients.

    Javed A, Jenkins SM, Labow B, et al.

    The breast journal 2019; (25(1)):91-95 doi:10.1111/tbj.13159.

    PMID: 30444280
  25. 25

    Diagnostic performance of ultrasound strain elastography for differentiation of malignant breast lesions.

    Georgieva M, Prantl L, Utpatel K, et al.

    Clinical hemorheology and microcirculation 2019; (71(2)):237-247 doi:10.3233/CH-189415.

    PMID: 30584133
  26. 26

    Benign Breast Tumours - Diagnosis and Management.

    Paepke S, Metz S, Brea Salvago A, Ohlinger R

    Breast care (Basel, Switzerland) 2018; (13(6)):403-412 doi:10.1159/000495919.

    PMID: 30800034
  27. 27

    Specialized Second Opinion Review of Breast MRI Impacts Management and Increases Cancer Detection.

    Weinfurtner RJ, Mooney B, Forbus J

    Journal of the American College of Radiology : JACR 2019; (16(7)):922-927 doi:10.1016/j.jacr.2019.01.006.

    PMID: 30833163
  28. 28

    Enlarging biopsy-proven fibroadenoma: Is surgical excision necessary?

    Dialani V, Chansakul T, Lai KC, et al.

    Clinical imaging 2019; (57()):35-39 doi:10.1016/j.clinimag.2019.03.014.

    PMID: 31103907
  29. 29

    Giant fibroadenoma with massive infarction masquerading as malignancy: a case report.

    Singh SK, Gupta P, Arora R, et al.

    International cancer conference journal 2017; (6(4)):167-170 doi:10.1007/s13691-017-0299-5.

    PMID: 31149495
  30. 30

    Ultrasound Guided Therapeutic Excisional Vacuum Assisted Biopsy in Breast Fibroadenomas.

    Buğdaycı O, Kaya H, Arıbal E

    The journal of breast health 2017; (13(2)):74-76 doi:10.5152/tjbh.2017.3038.

    PMID: 31244532
  31. 31

    Family History, Reproductive, and Lifestyle Risk Factors for Fibroadenoma and Breast Cancer.

    Li J, Humphreys K, Ho PJ, et al.

    JNCI cancer spectrum 2018; (2(3)):pky051 doi:10.1093/jncics/pky051.

    PMID: 31360866
  32. 32

    Benign Breast Disease in Women.

    Stachs A, Stubert J, Reimer T, Hartmann S

    Deutsches Arzteblatt international 2019; (116(33-34)):565-574.

    PMID: 31554551
  33. 33

    Surgeon-Performed Vacuum-Assisted Biopsy of the Breast: Results from a Multicentre Australian Study.

    Bennett I, de Viana D, Law M, Saboo A

    World journal of surgery 2020; (44(3)):819-824 doi:10.1007/s00268-019-05266-7.

    PMID: 31712841
  34. 34

    Minimally Invasive Breast Procedures: Practical Tips and Tricks.

    Huppe AI, Brem RF

    AJR. American journal of roentgenology 2020; (214(2)):306-315 doi:10.2214/AJR.19.22082.

    PMID: 31825258
  35. 35

    Main Traits of Breast Fibroadenoma Among Adolescent Girls.

    Sun C, Zhang W, Ma H, et al.

    Cancer biotherapy & radiopharmaceuticals 2020; (35(4)):271-276 doi:10.1089/cbr.2019.3209.

    PMID: 32267738
  36. 36

    Cancer Yield and Patterns of Follow-up for BI-RADS Category 3 after Screening Mammography Recall in the National Mammography Database.

    Berg WA, Berg JM, Sickles EA, et al.

    Radiology 2020; (296(1)):32-41 doi:10.1148/radiol.2020192641.

    PMID: 32427557
  37. 37

    Juvenile Fibroadenoma in a Four-Month-Old Male Infant.

    Van den Berge S, Keupers M, Breysem L

    Journal of the Belgian Society of Radiology 2020; (104(1)):42 doi:10.5334/jbsr.2155.

    PMID: 32743339
  38. 38

    Benign Disorders of the Breast in Pregnancy and Lactation.

    Taib NA, Rahmat K

    Advances in experimental medicine and biology 2020; (1252()):43-51 doi:10.1007/978-3-030-41596-9_6.

    PMID: 32816261
  39. 39

    Fibroadenomas: a multidisciplinary review of the variants.

    Basara Akin I, Balci P

    Clinical imaging 2021; (71()):83-100 doi:10.1016/j.clinimag.2020.10.058.

    PMID: 33186871
  40. 40

    A Diagnostic Enigma - A Rare Presentation Of Juvenile Fibroadenoma In A Premenarchal Girl.

    Nishtha , Kaur N, Tanveer N, Naskar S

    Journal of pediatric and adolescent gynecology 2021; (34(4)):558-560 doi:10.1016/j.jpag.2021.01.015.

    PMID: 33524609
  41. 41

    Carcinoma Breast-Like Giant Complex Fibroadenoma: A Clinical Masquerade.

    Nigam JS, Tewari P, Prasad T, et al.

    Cureus 2021; (13(1)):e12611 doi:10.7759/cureus.12611.

    PMID: 33585101
  42. 42

    The Positive Predictive Values of the Breast Imaging Reporting and Data System (BI-RADS) 4 Lesions and its Mammographic Morphological Features.

    Mohapatra SK, Mishra A, Sahoo TK, et al.

    Indian journal of surgical oncology 2021; (12(1)):182-189 doi:10.1007/s13193-020-01274-5.

    PMID: 33814852
  43. 43

    Giant breast fibroadenoma in pregnancy.

    Krhovský Miroslav, Pilka Radovan, Fait Vuk, Eim Josef

    Ceska gynekologie 2021; (86(2)):114-117 doi:10.48095/cccg2021114.

    PMID: 34020558
  44. 44

    Fibroepithelial tumours of the breast-a review.

    Lerwill MF, Lee AHS, Tan PH

    Virchows Archiv : an international journal of pathology 2022; (480(1)):45-63 doi:10.1007/s00428-021-03175-6.

    PMID: 34505197
  45. 45

    Efficacy and Safety of Vacuum-Assisted Excision for Benign Breast Mass Lesion: A Meta-Analysis.

    Yoo HS, Kang WS, Pyo JS, Yoon J

    Medicina (Kaunas, Lithuania) 2021; (57(11)) doi:10.3390/medicina57111260.

    PMID: 34833479
  46. 46

    Which lesions with a radiological or core biopsy diagnosis of fibroadenoma should be excised?

    Lee A, James J, Whisker L, et al.

    Annals of the Royal College of Surgeons of England 2022; (104(5)):361-366 doi:10.1308/rcsann.2021.0208.

    PMID: 34939848
  47. 47

    Prevalence of breast fibroadenoma in healthy physical examination population in Guangdong province of China: a cross-sectional study.

    Zhu L, Zeng X, Jiang S, et al.

    BMJ open 2022; (12(6)):e057080 doi:10.1136/bmjopen-2021-057080.

    PMID: 35760543
  48. 48

    A Single-Center Audit of BI-RADS 3 Assessment Category Utilization in Mammography and Breast Ultrasound.

    Common J, Abdullah P, Alabousi A

    Canadian Association of Radiologists journal = Journal l'Association canadienne des radiologistes 2023; (74(1)):69-77 doi:10.1177/08465371221121706.

    PMID: 36041944
  49. 49

    Fibroadenoma: a guide for junior clinicians.

    Hudson-Phillips S, Graham G, Cox K, Al Sarakbi W

    British journal of hospital medicine (London, England : 2005) 2022; (83(10)):1-9 doi:10.12968/hmed.2022.0070.

    PMID: 36322437
  50. 50

    Giant Juvenile Fibroadenoma: Case Report and Review of the Literature.

    Eleftheriades A, Tsarna E, Toutoudaki K, et al.

    Journal of clinical medicine 2023; (12(5)) doi:10.3390/jcm12051855.

    PMID: 36902642
  51. 51

    Learning curve in ultrasound-guided vacuum-assisted excision of breast lesions for surgeons and ultrasound physicians.

    Shen W, Sun Y, Song Y, et al.

    Quantitative imaging in medicine and surgery 2023; (13(3)):1478-1487 doi:10.21037/qims-22-573.

    PMID: 36915354
  52. 52

    ACR Appropriateness Criteria® Palpable Breast Masses: 2022 Update.

    , Klein KA, Kocher M, et al.

    Journal of the American College of Radiology : JACR 2023; (20(5S)):S146-S163 doi:10.1016/j.jacr.2023.02.013.

    PMID: 37236740
  53. 53

    Second opinion (external specialist referral) practice of breast pathology: the Nottingham experience.

    Rakha EA, Adebayo LA, Abbas A, et al.

    Histopathology 2023; (83(3)):394-405 doi:10.1111/his.14993.

    PMID: 37356966
  54. 54

    Efficacy and safety of vacuum-assisted excision (VAE) of fibroadenomas: experience in a tertiary centre.

    Carriero S, Depretto C, Cozzi A, et al.

    La Radiologia medica 2023; (128(10)):1199-1205 doi:10.1007/s11547-023-01684-9.

    PMID: 37530965
  55. 55

    Demystifying Breast Disease Markers.

    Wells VA, Medeiros I, Shevtsov A, et al.

    Radiographics : a review publication of the Radiological Society of North America, Inc 2023; (43(10)):e220151 doi:10.1148/rg.220151.

    PMID: 37676826
  56. 56

    Imaging and Management of Fibroepithelial Lesions of the Breast: Radiologic-Pathologic Correlation.

    Zhang M, Arjmandi FK, Porembka JH, et al.

    Radiographics : a review publication of the Radiological Society of North America, Inc 2023; (43(11)):e230051 doi:10.1148/rg.230051.

    PMID: 37856317
  57. 57

    Extending the Breast Cancer Surveillance Consortium Model of Invasive Breast Cancer.

    Gard CC, Tice JA, Miglioretti DL, et al.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2024; (42(7)):779-789 doi:10.1200/JCO.22.02470.

    PMID: 37976443
  58. 58

    European guidelines for the diagnosis, treatment and follow-up of breast lesions with uncertain malignant potential (B3 lesions) developed jointly by EUSOMA, EUSOBI, ESP (BWG) and ESSO.

    Rubio IT, Wyld L, Marotti L, et al.

    European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2024; (50(1)):107292 doi:10.1016/j.ejso.2023.107292.

    PMID: 38061151
  59. 59

    Understanding Fibroadenoma of the Breast: A Comprehensive Review of Pre-operative and Post-operative Clinicopathological Correlations.

    Pandit P, Murkey SP, Agarwal A, et al.

    Cureus 2023; (15(12)):e51329 doi:10.7759/cureus.51329.

    PMID: 38288219
  60. 60

    Correlation of Histopathology and Radiological Findings Among the Diverse Breast Lesions in a Tertiary Care Centre.

    Mohan R, Selvakumar A S, S R, et al.

    Cureus 2024; (16(1)):e52097 doi:10.7759/cureus.52097.

    PMID: 38344545
  61. 61

    Safety and Efficacy of Ultrasound-Guided Cryoablation for Benign Breast Fibroepithelial Lesions.

    Plaza MJ, Kumar AV, Sanchez-Gonzalez MA

    Journal of breast imaging 2019; (1(4)):324-328 doi:10.1093/jbi/wbz047.

    PMID: 38424801
  62. 62

    Giant juvenile fibroadenoma: A case report.

    El Graini S, El Hassouni F, Rouas L, et al.

    International journal of surgery case reports 2024; (121()):109897 doi:10.1016/j.ijscr.2024.109897.

    PMID: 38906040
  63. 63

    Ultrasound-guided cryoablation: Our experience in percutaneous treatment as an alternative to surgery for fibroadenomas of the breast lesions.

    Díaz de Bustamante Durbán T, Roca Navarro MJ, Navarro Monforte Y, et al.

    Radiologia 2024; (66(3)):228-235 doi:10.1016/j.rxeng.2022.12.011.

    PMID: 38908884
  64. 64

    One of the biggest and heaviest juvenile bilateral breast fibroadenoma: A case report.

    Al Hakkak SMM, Al Faham FSM, Awwady AN, et al.

    International journal of surgery case reports 2024; (121()):109954 doi:10.1016/j.ijscr.2024.109954.

    PMID: 38959615
  65. 65

    Role of ultrasound-guided vacuum-assisted breast biopsy in the management of radiologic-pathologic discordance: a retrospective single-centre study.

    Vatteroni G, Pinna G, Trimboli RM, et al.

    La Radiologia medica 2024; (129(10)):1454-1462 doi:10.1007/s11547-024-01864-1.

    PMID: 39102107
  66. 66

    Ultrasound-guided cryoablation of early breast cancer: safety, technical efficacy, patients' satisfaction, and outcome prediction with MRI/CEM: a pilot case-control study.

    Galati F, Pasculli M, Maroncelli R, et al.

    European radiology experimental 2024; (8(1)):120 doi:10.1186/s41747-024-00515-4.

    PMID: 39436590
  67. 67

    Effectiveness of ultrasound-guided vacuum-assisted excision for treating benign breast lesions.

    Tan X, Xuhong J, Ai X, et al.

    Cancer innovation 2025; (4(1)):e158 doi:10.1002/cai2.158.

    PMID: 39544723
  68. 68

    Understanding BI-RADS Category 3.

    Fazeli S, Stepenosky J, Guirguis MS, et al.

    Radiographics : a review publication of the Radiological Society of North America, Inc 2025; (45(1)):e240169 doi:10.1148/rg.240169.

    PMID: 39636752
  69. 69

    Role of centchroman in regression of fibroadenoma: A 2-arm randomized control trial.

    Rai P, Nityanand S, Singh A, et al.

    Clinics (Sao Paulo, Brazil) 2025; (80()):100567 doi:10.1016/j.clinsp.2024.100567.

    PMID: 39729836
  70. 70

    Classification of Fibroepithelial Lesions of the Breast in Core Needle Biopsy With Implications for Further Management.

    Rakha EA, Quinn C, Raymond W, et al.

    Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2025; (38(5)):100734 doi:10.1016/j.modpat.2025.100734.

    PMID: 39947480
  71. 71

    Trends, Outcomes, and Costs of Surgical Excisional Biopsy for Fibroadenoma of the Breast.

    Rath P, Vasigh M, Soleimani T, Euhus DM

    World journal of surgery 2025; (49(4)):797-803 doi:10.1002/wjs.12542.

    PMID: 40059293
  72. 72

    Patient experience and healthcare cost aspects of vacuum-assisted excision of breast lesions. A report from the Swedish VAE randomized clinical trial.

    Zouzos A, Fredriksson I, Karakatsanis A, et al.

    European journal of radiology 2025; (186()):112062 doi:10.1016/j.ejrad.2025.112062.

    PMID: 40127593
  73. 73

    Mammoplasty With Nipple-sparing Goldilocks Technique in Unilateral Gigantic Juvenile Fibroadenoma.

    Meghji NA, Mkoma I, Ngaiza A, et al.

    Plastic and reconstructive surgery. Global open 2025; (13(6)):e6894 doi:10.1097/GOX.0000000000006894.

    PMID: 40520496
  74. 74

    From Fibroadenoma to Phyllodes Tumor: Case Analysis of Borderline and Giant Breast Tumors with Literature Review.

    Kazlauskaitė J, Schmeil I

    Acta medica Lituanica 2025; (32(1)):190-205 doi:10.15388/Amed.2025.32.1.4.

    PMID: 40641528
  75. 75

    Efficacy and Safety of Centchroman in the Treatment of Breast Fibroadenoma: A Systematic Review and Meta-Analysis.

    Kumar K, Pallavi K, Martand K, et al.

    Cureus 2025; (17(6)):e87046 doi:10.7759/cureus.87046.

    PMID: 40741574
  76. 76

    Breast cryoablation for management of benign fibroadenomas: A systematic review of the literature.

    Ramgopal Y, Dodelzon K, Coffey K, Lamparello NA

    Clinical imaging 2025; (127()):110632 doi:10.1016/j.clinimag.2025.110632.

    PMID: 41061430
  77. 77

    Surgeon Performed Vacuum Assisted Breast Biopsy/Excision Is a Viable Paradigm for the Management of Benign and B3 Lesions-An Australian Multicenter Experience.

    Poels D, de Viana D, Van Wyngaard T, et al.

    World journal of surgery 2025; (49(12)):3343-3349 doi:10.1002/wjs.70132.

    PMID: 41068050
  78. 78

    American Society of Breast Surgeons and Society of Breast Imaging 2025 Guidelines for the Management of Benign Breast Fibroepithelial Lesions.

    Rosenberger LH, White RL, Tafra L, et al.

    JAMA surgery 2025; (160(12)):1378-1385 doi:10.1001/jamasurg.2025.4392.

    PMID: 41123921
  79. 79

    Follow-up Recommendations for Young, Average Risk Women With BI-RADS 3 Masses.

    Shpanskaya K, Nguyen DL, Grimm LJ, Ghate SV

    Journal of breast imaging 2026; (8(1)):22-31 doi:10.1093/jbi/wbaf042.

    PMID: 41217444
  80. 80

    Fibroepithelial Lesions: An Update for Daily Practice (Part-I).

    Long Chow Z, Gudi M, Tan PH

    Surgical pathology clinics 2025; (18(4)):675-699 doi:10.1016/j.path.2025.05.005.

    PMID: 41224412
  81. 81

    Subsequent breast cancer risk after benign breast biopsy in racially diverse women: Siteman Cancer Center.

    Koric A, Bennett DL, Boulos F, Colditz GA

    Journal of the National Cancer Institute 2026; (118(7)):1229-1237 doi:10.1093/jnci/djag048.

    PMID: 41697989
  82. 82

    A case of giant juvenile fibroadenoma in an adolescent girl: a case report.

    Adugna NB, Negasa GA, Terefe MT, et al.

    Journal of medical case reports 2026; (20(1)).

    PMID: 41821054
  83. 83

    Radiologic-Pathologic Discordance After Image-Guided Breast Biopsy: A Systematic Review of Prevalence and Outcomes.

    Yincharoen P, Sharma CP, Tawanwongsri W

    Medical sciences (Basel, Switzerland) 2026; (14(2)) doi:10.3390/medsci14020229.

    PMID: 42201021
  84. 84

    A deceptive fungating breast mass: giant fibroadenoma with multiple epidermal inclusion cysts mimicking malignancy.

    Heilat GB, Alrosan AZ, Muhsen RM, et al.

    Future science OA 2026; (12(1)):2728652 doi:10.1080/20565623.2026.2728652.

    PMID: 42700455
  85. 85

    Vacuum-Assisted Breast Biopsy and Post-Biopsy Scarring: Implications for Imaging Interpretation.

    Sardouk OE, Rizkallah J, Zeid FA, et al.

    Diagnostics (Basel, Switzerland) 2026; (16(17)) doi:10.3390/diagnostics16172705.

    PMID: 42739137